Population Relevance, Histology, and PD-L1 Considerations, our panel delve into the following critical questions: Is the ...

Results of a new study conclude that a pathology tool powered by artificial intelligence can predict whether a patient with ...

Researchers have built an AI-powered pathology tool designed to predict whether small cell lung cancer patients will respond ...

Invasive lung squamous cell carcinoma (LUSC) accounts for approximately one-quarter of all lung cancers, but therapeutic options for LUSC remain limited, primarily due to the absence of well-defined, ...

A quiet signal inside a tumor may soon guide how surgeons treat early lung cancer. Researchers now report that hidden genetic ...

Histology-first classification (adenocarcinoma versus squamous) remains foundational, with molecular profiling driving first-line selection and determining eligibility for recently approved targeted ...

Lung adenocarcinoma is the most common type of lung cancer diagnosed in the U.S. Just over half of all non-small-cell lung cancers (NSCLCs) are adenocarcinomas. Finding out that you're at risk of lung ...

Researchers have developed a pathology tool powered by AI that can predict whether a patient with extensive-stage small cell ...